Results

eNauka >  Rezultati >  Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) treated with pomalidamide and dexamethasone +/- subcutaneous daratumumab: Patient-reported outcomes (PROs) in APOLLO
Naziv: Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) treated with pomalidamide and dexamethasone +/- subcutaneous daratumumab: Patient-reported outcomes (PROs) in APOLLO
Autori Terpos, Evangelos; ...; Bila, Jelena S.  ; ...; (broj koautora 20)
Godina: 2021
Publikacija: Journal of clinical oncology (Virtual Annual Meeting of the American Society of Clinical Oncology (ASCO), Jun 04-08, 2021)
ISSN: 0732-183X Journal of Clinical Oncology Pretraži identifikator
Izdavač: Alexandria, VA : American Society of Clinical Oncology
Tip rezultata: Konferencijski rad
Kolacija: vol. 39 br. 15, Suppl str. 8046-8046
DOI: 10.1200/JCO.2021.39.15_suppl.8046
WoS-ID: 000708120604209
URI: https://enauka.gov.rs/handle/123456789/827032
URL: https://ascopubs.org/doi/10.1200/JCO.2021.39.15_suppl.8046
Projekat: Janssen Research & Development, LLC Other Foundation
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
Mp kategorija će biti prikazana naknadno.

1
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.